Zimmer Holdings ( ZMH) pushed the Health Services industry lower today making it today's featured Health Services loser. The industry as a whole closed the day up 0.2%. By the end of trading, Zimmer Holdings fell 45 cents (-0.7%) to $62.75 on average volume. Throughout the day, 1.8 million shares of Zimmer Holdings exchanged hands as compared to its average daily volume of 1.5 million shares. The stock ranged in price between $62.61-$63.68 after having opened the day at $62.76 as compared to the previous trading day's close of $63.20. Other company's within the Health Services industry that declined today were: Graymark Healthcare ( GRMH), down 15.7%, China Cord Blood ( CO), down 13.1%, Electromed ( ELMD), down 11.1%, and Dynacq Healthcare ( DYII), down 10.3%.

Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. Zimmer Holdings has a market cap of $10.68 billion and is part of the health care sector. The company has a P/E ratio of 14.7, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 13.5% year to date as of the close of trading on Friday. Currently there are nine analysts that rate Zimmer Holdings a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Zimmer Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, attractive valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the positive front, Enzo Biochem ( ENZ), up 10.2%, ImmunoCellular Therapeutics ( IMUC), up 9.1%, TearLab Corpoartion ( TEAR), up 8.3%, and Uroplasty ( UPI), up 7.9%, were all gainers within the health services industry with Humana ( HUM) being today's featured health services industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).